AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,550 | -32.1% | 108,900 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $72,963 | +55.8% | 108,900 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $46,827 | -0.6% | 108,900 | -27.9% | 0.00% | 0.0% |
| Q4 2022 | $47,097 | -46.5% | 151,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $88,000 | -25.4% | 151,000 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $118,000 | -31.0% | 151,000 | -6.2% | 0.00% | 0.0% |
| Q1 2022 | $171,000 | -14.1% | 161,000 | -25.5% | 0.00% | -25.0% |
| Q4 2021 | $199,000 | -58.3% | 216,000 | -8.5% | 0.00% | -55.6% |
| Q3 2021 | $477,000 | -9.8% | 236,000 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $529,000 | -14.0% | 246,000 | -9.2% | 0.01% | -18.2% |
| Q1 2021 | $615,000 | +209.0% | 271,000 | +144.1% | 0.01% | +175.0% |
| Q4 2020 | $199,000 | – | 111,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |